Shots:

• Prime Therapeutics launches MedDrive in multiple phases and provide a solution to help Blue Plan clients for greater biosimilar adoption and drug cost-saving strategies
• Prime helps the Blue Plan clients through a 100% transparent- unbiased PBM model that serves nearly 33M members across 23 Blue Plans
• Prime and Blue Cross plans to improve the use of biosimilars and other lower cost for effective treatment and to deliver improved affordability without compromising patient outcomes

  Ref: Prime Therapeutics | Image: Prime Therapeutics